IP Library Patent Application 11343417
Patent Application
App. No. 11/343,417

Rapid-response gas sensing element

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/343,417
Abstract

A gas analysis sensing element and a method of making the sensing element are disclosed. In one embodiment, the sensing element includes cytochrome c embedded in a sol-gel matrix. The sol-gel matrix is either a thin film or a monolith. Parameters for creating such a sensing element, including protein concentration, sol-gel pore size, surface area for the monolith embodiment, sol-gel components, and processing temperature, are also disclosed.

Claims (13)

1 . A method for detecting nitric oxide in a sample of exhaled breath at a concentration of 200 ppb or less, said method comprising:

contacting said exhaled breath in the gas phase with a xerogel monolith comprising cytochrome c encapsulated in a polymeric matrix, said xerogel monolith having a cytochrome c concentration of 1 mg/cc to 40 mg/cc, a pore diameter of 3.0 nm to 6.0 nm, and a surface area of 550 m 2 /g to 650 m 2 /g;

detecting a change in an optical property of said monolith as an indication of the binding of said nitric oxide to said cytochrome c; and

correlating any change so detected with the concentration of nitric oxide in said exhaled breath.

2 . The method of claim 1 wherein said nitric oxide concentration in said exhaled breath is 100 ppb or less.

3 . The method of claim 1 wherein said nitric oxide concentration in said exhaled breath is 50 ppb or less.

4 . The method of claim 1 wherein said pore diameter is 3.5 nm to 5.8 nm.

5 . The method of claim 1 wherein said cytochrome c concentration is from 20 mg/cc to 27 mg/cc.

6 . The method of claim 1 wherein said cytochrome c concentration is 25 mg/cc or less.

7 . The method of claim 1 wherein said cytochrome c concentration is from 8 mg/cc to 15 mg/cc.

8 . The method of claim 1 wherein said cytochrome c concentration is from 10 mg/cc to 12 mg/cc.

9 . The method of claim 1 wherein said monolith has a peak optical density of about 2.8 absorbance units at 400 nm.

10 . The method of claim 1 wherein said optical property is optical absorbance.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded May 28, 2010
From: SILICON VALLEY BANK
To: APIERON, INC. F/K/A APERON BIOSYSTEMS CORP.
Reel/Frame 024445/0943 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2010
From: APIERON, INC., F/K/A APERON BIOSYSTEMS CORP., BY AND THROUGH ITS CHAPTER 7 TRUSTEE, JANINA M. ELDER
To: AEROCRINE AB
Reel/Frame 024456/0478 →
SECURITY AGREEMENT Recorded Oct 5, 2009
From: APIERON, INC.
To: SILICON VALLEY BANK
Reel/Frame 023319/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2006
From: ANVAR, DAVID J.; PARIKH, BHAIRAVI R.; FAY, JONATHAN; CHAZAN, DAVID J.
To: APERON BIOSYSTEMS CORP.
Reel/Frame 017808/0511 →